SIGA Technologies, Inc.
General ticker "SIGA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $486.8M (TTM average)
SIGA Technologies, Inc. follows the US Stock Market performance with the rate: 46.5%.
Estimated limits based on current volatility of 1.7%: low 6.05$, high 6.26$
Factors to consider:
- Company pays dividends (annually): last record date 2025-04-29, amount 0.60$ (Y9.46%)
- Total employees count: 46 (+2.2%) as of 2024
- US accounted for 83.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Government contract risks, Manufacturing risks, Non government sales dependency, Geopolitical risks, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.56$, 8.39$]
- 2025-12-31 to 2026-12-31 estimated range: [4.27$, 7.99$]
Financial Metrics affecting the SIGA estimates:
- Positive: with PPE of 7.3 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 50.45 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 19.51 > 6.04
- Positive: 6.82 < Operating cash flow per share per price, % of 11.51
- Positive: Inventory ratio change, % of -5.13 <= -0.75
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 88.32 > 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SIGA quotes
Long-term SIGA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $110.78MM | $139.92MM | $138.72MM |
| Operating Expenses | $68.08MM | $56.30MM | $68.74MM |
| Operating Income | $42.70MM | $83.62MM | $69.98MM |
| Non-Operating Income | $1.43MM | $4.16MM | $6.09MM |
| R&D Expense | $22.53MM | $16.43MM | $12.31MM |
| Income(Loss) | $44.13MM | $87.78MM | $76.07MM |
| Taxes | $10.23MM | $19.71MM | $16.86MM |
| Profit(Loss)* | $33.90MM | $68.07MM | $59.21MM |
| Stockholders Equity | $170.16MM | $196.86MM | $215.80MM |
| Inventory | $39.27MM | $64.22MM | $49.56MM |
| Assets | $195.04MM | $254.35MM | $244.34MM |
| Operating Cash Flow | $41.61MM | $94.80MM | $48.76MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.04MM |
| Investing Cash Flow | $0.00MM | $-0.02MM | $-0.04MM |
| Financing Cash Flow | $-45.96MM | $-43.42MM | $-43.46MM |
| Earnings Per Share** | $0.46 | $0.95 | $0.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.